Trials / Completed
CompletedNCT00232752
Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
A Multicenter, Non-Randomized Study of the 4.0mm Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess the safety and effectiveness of the sirolimus-eluting Bx VELOCITYTM stent in reducing in-lesion late loss in patients with de novo native coronary artery lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 4.0 CYPHER Sirolimus-Eluting Coronary Stent | 4.0 CYPHER Sirolimus-Eluting Coronary Stent |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2005-01-01
- Completion
- 2009-11-01
- First posted
- 2005-10-05
- Last updated
- 2009-12-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00232752. Inclusion in this directory is not an endorsement.